<List><item><source>MED</source><extId>25848203</extId><pmcid>PMC4376306</pmcid><annotations><annotation><prefix>tes Mellitus [RISE, </prefix><exact>NCT00473330</exact><postfix>], Ranibizumab Injec</postfix><tags><tag><name>NCT00473330</name><uri>http://identifiers.org/clinicaltrials/NCT00473330</uri></tag></tags><id>http://europepmc.org/articles/PMC4376306#europepmc-149b251a4b13ffc7e6c25636623caa9a</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>tes Mellitus [RIDE, </prefix><exact>NCT00473382</exact><postfix>]) examining the eff</postfix><tags><tag><name>NCT00473382</name><uri>http://identifiers.org/clinicaltrials/NCT00473382</uri></tag></tags><id>http://europepmc.org/articles/PMC4376306#europepmc-05e3d7ac5afba9098e4132c0ef6084a9</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>